Literature DB >> 24403855

Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.

Tal Leibovich-Rivkin1, Yulia Liubomirski1, Biana Bernstein1, Tsipi Meshel1, Adit Ben-Baruch1.   

Abstract

Nontransformed breast epithelial cells that are adjacent to tumor cells are constantly exposed to tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β), two inflammatory cytokines identified as having pro-tumoral causative roles. We show that continuous stimulation of nontransformed breast epithelial cells by TNFα + IL-1β for 2 to 3 weeks induced their spreading and epithelial-to-mesenchymal transition (EMT). The mechanistic bases for this slow induction of EMT by TNFα + IL-1β are: 1) it took 2 to 3 weeks for the cytokines to induce the expression of the EMT activators Zeb1 and Snail; 2) although Twist has amplified the EMT-inducing activities of Zeb1 + Snail, its expression was reduced by TNFα + IL-1β; however, the lack of Twist was compensated by prolonged stimulation with TNFα + IL-1β that has potentiated the EMT-inducing activities of Zeb1 + Snail. Stimulation by TNFα + IL-1β has induced the following dissemination-related properties in the nontransformed cells: 1) up-regulation of functional matrix metalloproteinases; 2) induction of migratory and invasive capabilities; 3) disruption of the normal phenotype of organized three-dimensional acini structures typically formed only by nontransformed breast cells and spreading of nontransformed cells out of such acini. Our findings suggest that TNFα + IL-1β induce dissemination of nontransformed breast epithelial cells and their reseeding at the primary tumor site; if, then, such detached cells are exposed to transforming events, they may form secondary malignant focus and lead to disease recurrence. Thus, our study reveals novel pathways through which the inflammatory microenvironment may contribute to relapsed disease in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24403855      PMCID: PMC3884524          DOI: 10.1593/neo.131688

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  95 in total

Review 1.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 2.  Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.

Authors:  Jodi E Goldberg; Kathryn L Schwertfeger
Journal:  Curr Drug Targets       Date:  2010-09       Impact factor: 3.465

3.  Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative).

Authors:  Ignacio García-Tuñón; Mónica Ricote; Antonio Ruiz; Benito Fraile; Ricardo Paniagua; Mar Royuela
Journal:  Cancer Sci       Date:  2006-10       Impact factor: 6.716

4.  Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.

Authors:  I M El Agouza; S S Eissa; M M El Houseini; Dalia E El-Nashar; O M Abd El Hameed
Journal:  Angiogenesis       Date:  2011-05-08       Impact factor: 9.596

5.  Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.

Authors:  Chia-Wei Li; Weiya Xia; Longfei Huo; Seung-Oe Lim; Yun Wu; Jennifer L Hsu; Chi-Hong Chao; Hirohito Yamaguchi; Neng-Kai Yang; Qingqing Ding; Yan Wang; Yun-Ju Lai; Adam M LaBaff; Ting-Jung Wu; Been-Ren Lin; Muh-Hwa Yang; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2012-01-17       Impact factor: 12.701

Review 6.  Role of IL-1-mediated inflammation in tumor angiogenesis.

Authors:  Elena Voronov; Yaron Carmi; Ron N Apte
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells.

Authors:  R Dong; Q Wang; X L He; Y K Chu; J G Lu; Q J Ma
Journal:  Braz J Med Biol Res       Date:  2007-08       Impact factor: 2.590

8.  Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue.

Authors:  D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

9.  Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR).

Authors:  Nathan R West; Valerie Panet-Raymond; Pauline T Truong; Cheryl Alexander; Sindy Babinszky; Katy Milne; Louetta A Ross; Steven Loken; Peter H Watson
Journal:  Breast Cancer (Auckl)       Date:  2011-05-31

10.  Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.

Authors:  Johanna R Reed; Ronald P Leon; Majken K Hall; Kathryn L Schwertfeger
Journal:  Breast Cancer Res       Date:  2009-04-24       Impact factor: 6.466

View more
  22 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma.

Authors:  Wenda Li; Xue Zhou; ZeJian Huang; Hongwei Zhang; Lei Zhang; Changzhen Shang; Yajin Chen
Journal:  Surg Endosc       Date:  2014-12-25       Impact factor: 4.584

Review 3.  The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.

Authors:  Hui Li; Fangying Xu; Si Li; Anjing Zhong; Xianwen Meng; Maode Lai
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 4.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

Review 5.  Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.

Authors:  Julio Valdivia-Silva; Jaciel Medina-Tamayo; Eduardo A Garcia-Zepeda
Journal:  Int J Mol Sci       Date:  2015-06-08       Impact factor: 5.923

6.  Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.

Authors:  Yitao Jia; Suqiao Zhang; Lingling Miao; Jingbao Wang; Zujian Jin; Bin Gu; Zhihui Duan; Zhaolong Zhao; Shunmao Ma; Wenjin Zhang; Zhongxin Li
Journal:  Oncol Rep       Date:  2015-04-03       Impact factor: 3.906

Review 7.  Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.

Authors:  Stephan Lindsey; Sigrid A Langhans
Journal:  Front Oncol       Date:  2014-12-11       Impact factor: 6.244

8.  Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival.

Authors:  Masanori Oshi; Yoshihisa Tokumaru; Fernando A Angarita; Lan Lee; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

9.  HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.

Authors:  Yue-Mei Xu; Hong-Jiang Wang; Fang Chen; Wan-Hua Guo; Yan-Yang Wang; Hang-Yu Li; Jin-Hai Tang; Ying Ding; Ya-Chen Shen; Min Li; Wen-Ying Xuan; Lin-Hui Liu; Jia Wang; Xue-Rong Wang; Ze-Jun Gao; Xiu-Bin Liang; Dong-Ming Su
Journal:  Oncotarget       Date:  2015-12-15

10.  Helicobacter pylori CagA and IL-1β Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model.

Authors:  Haruki Arévalo-Romero; Isaura Meza; Gabriela Vallejo-Flores; Ezequiel M Fuentes-Pananá
Journal:  Gastroenterol Res Pract       Date:  2016-07-20       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.